Classifications

• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
  • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
  • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
  • A61K8/89—Polysiloxanes
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
  • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
  • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
  • A61K8/89—Polysiloxanes
  • A61K8/895—Polysiloxanes containing silicon bound to unsaturated aliphatic groups, e.g. vinyl dimethicone
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
  • A61K8/0216—Solid or semisolid forms
  • A61K8/022—Powders; Compacted Powders
  • A61K8/0225—Granulated powders
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
  • A61K8/0241—Containing particulates characterized by their shape and/or structure
  • A61K8/0279—Porous; Hollow
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
  • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
  • A61K8/25—Silicon; Compounds thereof
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
  • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
  • A61K8/26—Aluminium; Compounds thereof
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
  • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
  • A61K8/73—Polysaccharides
  • A61K8/732—Starch; Amylose; Amylopectin; Derivatives thereof
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
  • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
  • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
  • A61K8/89—Polysiloxanes
  • A61K8/896—Polysiloxanes containing atoms other than silicon, carbon, oxygen and hydrogen, e.g. dimethicone copolyol phosphate
  • A61K8/898—Polysiloxanes containing atoms other than silicon, carbon, oxygen and hydrogen, e.g. dimethicone copolyol phosphate containing nitrogen, e.g. amodimethicone, trimethyl silyl amodimethicone or dimethicone propyl PG-betaine
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
  • A61Q5/00—Preparations for care of the hair
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
  • A61Q5/00—Preparations for care of the hair
  • A61Q5/02—Preparations for cleaning the hair
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
  • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
  • A61K2800/30—Characterized by the absence of a particular group of ingredients
  • A61K2800/31—Anhydrous
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
  • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
  • A61K2800/41—Particular ingredients further characterized by their size
  • A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
  • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
  • A61K2800/60—Particulates further characterized by their structure or composition
  • A61K2800/61—Surface treated
  • A61K2800/62—Coated
  • A61K2800/624—Coated by macromolecular compounds
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
  • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
  • A61K2800/60—Particulates further characterized by their structure or composition
  • A61K2800/65—Characterized by the composition of the particulate/core
  • A61K2800/654—The particulate/core comprising macromolecular material

Definitions

• a granulated powder to be used as a dry cleanser for keratinous substrates with high speed of absorption of body fluids together with improved sensory feel and release of care agents By dry is generally meant that water is not needed during application.
• cleaning to include cleaning personal care product which is designed to clean skin or hair for animals as well as for human beings.
• a dry cleanser is designed to remove body fluids, such as sebum, perspiration and malodor, dirt, skin particles, dandruff, environmental pollutants or other contaminant particles that gradually build up on keratinous substrates.
• the personal care product may be functional with respect to the portion of the body to which it is applied; it can be cosmetic, therapeutic, or some combination thereof, through the release of care agents such as sensory agent, shine agent, coloring agent, fragrance, moisturizing agent or refreshing agent.
• the cleanser as described herein is in the form of a powder able to clean hair or skin in the absence of water.
• Cleansers are usually sold in liquid format and require the use of water and the drying of the keratinous substrate afterwards. There is however a requirement for dry application, i.e. in the absence of water, particularly if water is not available or not allowed, e.g. travels, hospital or during working hours, or if there are some transportation restriction, e.g. in airports. To sufficiently absorb sebum, a dry cleanser needs to be left long enough on the keratinous substrate, thus limiting their use. There is therefore the need to enhance the speed of absorption and thus reduce the needed contact time with the keratinous substrate.
• a granulated dry composition comprising at least one non- elastomeric polyorganosiloxane, agglomerated onto solid carrier particles.
• granules we mean agglomerated particles, typically free flowing particles, as opposed to slurry
• the granules comprise carrier particles upon which a liquid non-elastomeric polyorganosiloxane containing composition is deposited in combination with optional care agents and which exhibit fast absorbency.
• the granulated dry composition is prepared by contacting a liquid non-elastomeric polyorganosiloxanes containing composition (liquid composition), with a solid particulate carrier composition (carrier) under conditions such that the liquid composition is
• the agglomerated product being kept in granule form during agglomeration or subsequently formed into granules.
• the granulated dry composition absorbs body fluids faster and is perceived as providing a pleasant feel on the hair or skin.
• the granulated dry composition may be packaged in various types of packaging or dispenser, such as but not limited to sachet, flask, aerosol.
• the solid particulate carriers which may be used in the invention include zeolites, for example Zeolite 4A or Zeolite X, and other aluminosilicates or silicates, for example magnesium silicate, calcium silicate, sodium silicate, mica, bentonite, diatomite, sepiolite, natural or modified clays, such as that sold under the Trade Mark 'Laponite XG', talc, neat or treated silica, cellulose, alginates, chitin, chitosan, starch, for example granulated starch or native starch, calcium sulphate, calcium carbonate, sodium sulphate, sodium acetate, magnesium sulphate, phosphates, for example powdered or granular sodium
• the mean particle size of a soft solid particulate carrier which contacts the liquid composition is generally from 1 micrometer to 250 micrometers, alternatively from 1 to 100 micrometers, alternatively from 2 up to 15 or 30 micrometers.
• the mean particle size of a hard solid particulate carrier is 1 to 30 micrometers, alternatively 1 to 20 micrometers, alternatively 1 to 10 micrometers.
• the liquid composition comprises at least one non-elastomeric polyorganosiloxane, optionally a binder and optionally a cosmetic ingredient.
• non-elastomeric polyorganosiloxanes which may be used herein may be in the form of oils, waxes, resins or gums, possibly modified with organic moieties, and may be soluble or non soluble in the liquid composition. They may be volatile or non- volatile. Any combination or mixture of different non-elastomeric polyorganosiloxanes may also be used. Such non-elastomeric polyorganosiloxanes are known to the person skilled in the art as are methods for making them and many of them commercially available. Elastomeric polyorganosiloxane do not form part of the polyorganosiloxanes which may be used herein.
• Volatile non-elastomeric polyorganosiloxanes are typically those having a boiling point below 25O 0 C, such as (i) cyclic polyorganosiloxanes containing from 3 to 7 alternatively from 5 to 6 silicon atoms; (ii) linear volatile polyorganosiloxanes having 2 to 9 silicon atoms and having a viscosity of less than or equal to 5 mm ⁇ /s at 25 0 C.
• the volatile non-elastomeric polyorganosiloxanes may also be mixtures of (i) and (ii).
• the volatile non- elastomeric polyorganosiloxanes may be further exemplified by volatile methyl siloxane or volatile ethyl siloxanes.
• Non- volatile non-elastomeric polyorganosiloxanes may be exemplified by polyalkylsiloxanes, polyarylsiloxanes, polyalkylarylsiloxanes, polyorganosiloxane gums and resins, polyorganosiloxanes modified with organofunctional groups, and mixtures thereof.
• polyalkylsiloxanes are polydimethylsiloxanes containing trimethylsilyl end groups (CTFA designation Dimethicone) having a viscosity of from 5 mm ⁇ /s to 2.5 million mm ⁇ /s at 25° C, alternatively 10 to 1 million mm ⁇ /s. Also suitable are
• CTFA designation polydimethylsiloxanes containing dimethylsilanol end groups
• Polyalkylarylsiloxanes which are useful may be chosen from linear and branched polydimethylmethylphenylsiloxanes and polydimethyldiphenylsiloxanes with a viscosity of from 10 to 50 000 mm 2 /s at 25 0 C.
• the non-elastomeric polyorganosiloxane may be in the form of a gum. Gums are typically polydiorganosiloxanes having a molecular weight in the range of 200,000 and 1,000,000, used alone or in conjunction with a solvent. This solvent may be chosen from volatile polyorganosiloxanes, polydimethylsiloxane (PDMS) oils, isoparaffins, hydrocarbon solvents, or mixtures thereof.
• PDMS polydimethylsiloxane
• the non-elastomeric polyorganosiloxane may be a resin.
• Non-elastomeric polyorganosilxoxane resins which may be used herein typically consist of siloxane units of the general formula R"Si ⁇ 3/2 wherein R" denotes a hydrocarbon-based group having from 1 to 16 carbon atoms or a phenyl group; alternatively a Ci - C4 lower alkyl radical;
• non-elastomeric polyorganosiloxane resins usefule herein may be used alone or in conjunction with a solvent.
• the resins may be exemplified by an organopolysiloxane resin (CTFA designation Trimethylsiloxysilicate) or those described in US 5152984 and US 5126126 , such as Aminopropyl Phenyl
• Non-elastomeric polyorganosiloxanes modified with an organofunctional group may be used herein.
• organomodified polyorganosiloxane By modified with an organofunctional group, organomodified polyorganosiloxane
• organofunctional group it is meant polyorganosiloxanes containing in their structure one or more organofunctional groups attached via a Si-C or Si-O-C linkage.
• organomodified polyorganosiloxane is polyorganosiloxanes containing polyethylenoxy and/or polypropylenoxy groups, optionally containing Cg-C24 alkyl groups and substituted or unsubstituted amine groups such as Ci- C4 aminoalkyl groups
• aminofunctional polyorganosiloxanes are those having the formula
• R 2 R2Si0(R2 SiO) ⁇ R 1 RSiO)bSiR2R 2 or R 2 R 2 SiO ⁇ SiO) ⁇ R 1 Si ⁇ 3/2)bSiR2R 2
• R is a monovalent hydrocarbon radical
• R 1 is an aminoalkyl group having its formula selected from the group consisting of -R- ⁇ NH 2 and -R ⁇ NHR ⁇ NH 2 wherein R ⁇ is a divalent hydrocarbon radical having at least 3 carbon atoms and R ⁇ is a divalent hydrocarbon radical having at least 2 carbon atoms
• R 2 is selected from the group consisting of R, R.1, and -OH, typically -OH; subscript a has a value of 0 to 2000, alternatively 50 to 2000, and subscript b has a value of from greater than zero to 200 , alternatively 1 to 100.
• the R radicals are exemplified by alkyl radicals such as the methyl, ethyl, propyl, butyl, amyl, and hexyl, alkenyl radicals such as the vinyl, allyl, and hexenyl, cycloalkyl radicals such as the cyclobutyl and cyclohexyl, aryl radicals such as the phenyl and naphthyl, aralkyl radicals such as the benzyl and 2- phenylethyl, alkaryl radicals such as the tolyl, and xylyl, halohydrocarbon radicals such as 3- chloropropyl, 4-bromobutyl, 3,3,3-trifluoropropyl, chlorocyclohexyl, bromophenyl, and chlorophenyl.
• R is a monovalent hydrocarbon radical having from 1 to 6 carbon atom
• R ⁇ is typically an alkylene radical having from 3 to 20 carbon atoms such as propylene, -CH2CHCH3-, butylene,
• R ⁇ is typically an alkylene radical having from 2 to 20 carbon atoms such as ethylene, propylene, -CH2 CHCH3-, butylene, -CH 2 CH(C ⁇ )CH 2 -, pentamethylene, hexamethylene, 3-ethyl-hexamethylene,
• R 1 are CH 2 CH 2 CH 2 NHCH 2 CH 2 NH 2 and
• salts include alkyl carboxylate salts, aryl carboxylate salts, halide salts such as chlorides and bromides, and other neutralization products of the amines with organic acids.
• the aminofunctional polyorganosiloxanes typically have from 0.1 to 15 mol% of the above described amino groups alternatively from 0.2 to 10 mol%.
• the aminofunctional polyorganosiloxanes useful in this invention may be prepared by procedures well known in the art. Many of these polyorganosiloxanes are available commercially.
• alkoxylated groups or hydroxyl groups, as described in EP 1081272, US 6171515 and US 6136215 such as Bis-Hydroxy/Methoxy Amodimethicone.
• amino-acid functional siloxanes obtained by reacting an amino acid derivative selected from the group of an N-acyl amino acid and an N-aroyl amino acid with an amino functional siloxane, further described in WO 2007/141565.
• aminofunctional polyorganosiloxanes which may be used herein are quaternary ammonium functional polyorganosiloxanes, described in US 6482969 and US 6607717, such as Polyorganosiloxane Quaternium-16 (CTFA designation).
• amino ABn polyorganosiloxane polyether block copolymer where an amino functionality is added to the ABn polyorganosiloxane polyether copolymer, also described in IP.COM 00141525 such as Bis-Isobutyl PEG/PPG-20/35/Amodimethicone Copolymer (CTFA designation).
• organomodified polyorganosiloxanes which may be used herein are water soluble or water dispersible polyorganosiloxane polyether compositions. These are also known as polyalkylene oxide polyorganosiloxane copolymers, polyorganosiloxane poly(oxyalkylene) copolymers, polyorganosiloxane glycol copolymers, or
• polyorganosiloxane surfactants may be linear rake or graft type materials, or ABA and ABn types where the B is the siloxane polymer block, and the A is the poly(oxyalkylene) group.
• the poly(oxyalkylene) group may consist of polyethylene oxide, polypropylene oxide, or mixed polyethylene oxide/polypropylene oxide groups. Other oxides, such as butylene oxide or phenylene oxide are also possible.
• organomodified polyorganosiloxanes which may be used herein are
• hydrocarbyl functional organopolysiloxanes comprising a siloxy unit of the formula
• R ⁇ R ⁇ SiO ⁇ -i)/! wherein R' is any monovalent hydrocarbon group, but typically is an alkyl, cycloalkyl, alkenyl, alkaryl, aralkyl, or aryl group containing 1-20 carbon atoms, R ⁇ is a hydrocarbyl group having the formula -R6OCH2CH2OH, wherein R ⁇ is a divalent hydrocarbon group containing 2 to 6 carbon atoms and i has a value of from zero to 2.
• hydrocarbyl functional organopolysiloxanes are further described in US 2823218, US 5486566, US 6060044 and US 20020524.
• the hydrocarbyl functional organopolysiloxanes may be exemplified by those designated by CTFA as Bis-Hydroxyethoxypropyl
• Yet another organomodified polyorganosiloxane which may be used herein may be siloxane-based polyamide.
• US 6051216 discloses siloxane-based polyamides as gelling agents for cosmetic products, methods for making such agents, and formulations thereof. Such polyamides contain siloxane groups in the main chain and act to thicken compositions containing volatile and/or non-volatile polyorganosiloxane fluids. Variants of siloxane-based polyamides such as polyorganosiloxane polyether-amide block copolymers described in US 2008/004568, may also be used herein.
• organomodified polyorganosiloxanes which may be used herein may be vinyl-type polymer having a carbosiloxane dendrimer structure on their side molecular chain. These may be used as neat polymer or as a solution or a dispersion in a liquid such as a polyorganosiloxane oil, organic oil, alcohol, or water. Such polymers which may be used herein are further described in EP 0963751, and are given the CTFA designation
• organomodified polyorganosiloxanes which may be used herein may be alkylmethylsiloxane materials which may be present as liquids or waxes. In liquid form they
• each R ' is independently a hydrocarbon of 6 to 30 carbon atoms
• R 8 is methyl or R 7
• p is 1-6
• q is 0-5
• w is 0-5
• x is
• liquids may be either volatile or non-volatile and they can have a wide range of viscosities such as from 0.65 to 50,000 mm 2 /s at 25°C.
• Alkylmethylsiloxane waxes have the structure
• R 8 Me2SiO(Me2SiO) y (MeR 7 SiO) z SiMe2R 8 wherein y is 0-100, z is 1-100, R 7 is an alkyl group of 6-30 carbon atoms and R 8 is methyl or R 7 .
• the alkylmethylsiloxane has the formula Me3SiO(Me2SiO)y(Me R 7 Si0) z SiMe3. These alkylmethylsiloxane materials are known in the art and can be produced by known methods.
• organomodified polyorganosiloxanes which may be used herein may be polyorganosiloxane quaternary ammonium compounds or monoquaternary ammonium functional derivatives of alkanolamino polydimethylsiloxanes, such as disclosed in US 5026489.
• the derivatives are exemplified by ⁇ 3 SiO) 2 Si R9(CHR 1 0) c NR 10 d R 1 1 3 _ d wherein R 9 is an alkyl group, R 10 is H, alkyl, or aryl, R 1 1 is (CHR 10 )OH, c is 1 to 10, and d is 1 to 3.
• organomodified polyorganosiloxanes which may be used herein may be saccharide-siloxane copolymer having a saccharide component and an organosiloxane component and linked by a linking group, such as described in WO 2006/127883, EP 1885331 and US 2008/0199417.
• the saccharide- siloxane copolymer has the following formula: R 12 e R 13 ( 3 . e )Si0[( SiR 12 R 13 O) m ( SiR 12 O) n ] v SiR 13 (3_ e )R 12 e
• each R 13 may be the same or different and comprises hydrogen, C 1 -C 12 alkyl, an organic radical, or R 3 -W, W comprises an epoxy, cycloepoxy, primary or secondary amino, ethylenediamine, carboxy, halogen, vinyl, allyl, anhydride, or mercapto functionality, m and n are integers from 0 to 10,000 and may be the same or different, each e is independently 0, 1, 2, or 3, v is an integer such that the copolymer has a molecular weight less than 1 million,
• RI 2 has the formula -Z(Gl)f(G 2 ) ⁇ , and there is at least one R 12 per copolymer, wherein G 1 is a saccharide component comprising 5 to 12 carbons, f+g is 1 tolO, f or g can be 0, G 2 is a saccharide component comprising 5 to 12 carbons additionally substituted with organic or organosilicon radicals, Z is the linking group and is independently selected from the group consisting of: R 15 NHC(O)R 16 -; R 15 NHC(O)OR 16 -; R 15 NH-C(O)NHR 16 -;
• R 17 and R 19 are either Cl-C ⁇ 2 alkyl or ((Ci-Ci 2 )O) ⁇ where k is any integer 1-50 and each (Ci-Ci 2 )O may be the same or different, R 18 is -N(R 2 O)-, where R 2 ⁇ is H or Ci-Ci 2 alkyl, or is Z-X where Z is previously defined or R 15 .
• X is a carboxylic acid, phosphate, sulfate, sulfonate or quaternary ammonium radical, and at least one of R 15 and R 16 must be present in the linking group and may be the same or different, and wherein the saccharide-siloxane copolymer is a reaction product of a functionalized organosiloxane polymer and at least one hydroxy-functional saccharide such that the organosiloxane component is covalently linked via the linking group,
• saccharide-siloxane copolymer which may be used herein may be ionically- modified saccharide siloxane copolymers, such as described in WO 2006/127924.
• Organofunctional polyorganosiloxanes having at least one substituent that is a sulfonate group are useful herein.
• the sulfonate groups typically has the formula
• R 21 is a divalent organic group bonded to the
• organopolysiloxane Y is hydrogen, an alkali metal, or a quaternary ammonium; G is an oxygen atom, NH, or an NR ⁇ 2 group where R ⁇ 2 [ S a monovalent organic group such as those having 1 to 20 carbon atoms, alternatively 1 to 10 carbon atoms, and Ph is a phenyl cycle.
• the sulfonate group substituent is bonded to the organopolysiloxane via a Si-C bond by the
• R.21 is typically a divalent hydrocarbon group containing 2 to 6 carbon atoms such as ethylene, propylene, butylene, pentylene, or hexylene group.
• R.21 is a propylene group, -CH2CH2CH2- or an isobutylene group, -CH2CH(CH3)CH2-.
• G in the general formula for the sulfonate substituent group above is an oxygen atom, NH, or an NR ⁇ 2 group where R ⁇ 2 [ s a monovalent organic group.
• G is NH.
• R may be exemplified by, but not limited to alkyl groups such as methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, undecyl, and octadecyl; cycloalkyl such as cyclohexyl; aryl such as phenyl, tolyl, xylyl, benzyl, and 2-phenylethyl; amine functional organic groups such as aminopropyl and aminoethylaminoisobutyl; a polyalkylene oxide (polyether) such as polyoxyethylene, polyoxypropylene, polyoxybutylene, or mixtures thereof, and halogenated hydrocarbon groups such
• non-elastomeric polyorganosiloxanes useful herein include non-volatile polyorganosiloxanes chosen from the family of polyalkylsiloxanes containing trimethylsilyl end groups, polyalkylsiloxanes containing dimethylsilanol end groups, such as dimethiconol, polysiloxanes containing amine groups, such as amodimethicones or
• polypropylenoxy groups hydrocarbyl functional organopolysiloxane and mixtures of two or more of these. Also useful are emulsions of any of these and in situ polymerized emulsions.
• the polyorganosiloxane is typically liquefied before adding to the solid particulate composition.
• the polyorganosiloxanes may be in the form of a fluid or an emulsion or a suspension when it is mixed with the solid particulate composition.
• the water present in the emulsion or suspension forms some or all of the water required to solubilize the other ingredients present in the liquid
• composition Suitable polydiorganosiloxane emulsions are described for example in EP 432951, EP 798332, EP 0874017, US 6013682, EP 1263840 and EP 1054032.
• a binder may also be added to improve the stability of the granules.
• binders are polycarboxylates, for example polyacrylic acid or a partial sodium salt thereof or a copolymer of acrylic acid, for example a copolymer with maleic anhydride, polyoxyalkylene polymers such as polyethylene glycol, which may be applied molten or as an aqueous solution, reaction products of tallow alcohol and ethylene oxide, or cellulose ethers, particularly water-soluble or water-swellable cellulose ethers such as sodium carboxymethylcellulose, or sugar syrup binders such as Polysorb 70/12/12 or LYCASIN 80/55 HDS maltitol syrup or Roclys C 1967 S maltodextrin solution.
• Polycarboxylate binders are water soluble polymers, copolymers or salts thereof. They have at least 60% by weight of segments with the general formula:
• A, Q and Z are each selected from the group consisting of hydrogen, methyl, carboxy, carboxymethyl, hydroxy and hydroxymethyl
• M is hydrogen, alkali metal, ammonium or substituted ammonium and v is from 30 to 400.
• A is hydrogen or hydroxy
• Q is hydrogen or carboxy
• Z is hydrogen.
• Suitable polymeric polycarboxylates include polymerised products of unsaturated monomeric acids, e.g. acrylic acid, maleic acid, maleic anhydride, fumaric acid, itaconic acid, aconitic acid, mesaconic acid, citraconic acid and methylenemalonic acid. The copolymerisation with lesser amounts of monomeric materials comprising no carboxylic acid, e.g. vinylmethyl, vinylmethylethers, styrene and ethylene is not detrimental to the use of the polycarboxylates of the present invention.
• this level can be kept low, or levels can be up to 40% by weight of the total polymer or copolymer.
• the polycarboxylates binders are polyacrylates having an average viscosity at 25 0 C in mPa.s from 50 to 10,000, alternatively 2,000 to 8,000 and a molecular weight of 1,000 to 500,000, alternatively 3,000 to 100,000, alternatively 15,000 to 80,000.
• Examples of polycarboxylate binders are acrylate/maleate or acrylate/fumarate copolymers or their sodium salts having a ratio of acrylate to maleate or fumarate segments from 30:1 to 2: 1.
• the binder may be mixed with the liquid composition before being deposited on the carrier, or alternatively is deposited on the carrier particles either at the same time or subsequently to the liquid carrier, or at both times.
• the binder should be liquid, being solubilised or molten.
• the binder may be used at 0.1 to 10% by weight of the granulated dry composition.
• the granulated dry compositions may contain other ingredients or additive substances such as perfumes, fragrances, colorants such as dyes, essential oils, deposition agents such as polyquaternary compounds to improve the deposition of additive substances from the dry cleanser onto hair or skin, buffering agents, stabilizers, proteins, preservatives, anti-dandruff agent, disinfectants, glycols, polyols such as glycerine and propylene glycol, vitamins and/or their derivatives, styling agents, sunscreen agents, humectants, oil components, emollients, esters, ceramides, soothing ingredients, antiper spirants, malodor sequestrants, surfactants, amino-acid derivatives, antioxidants, botanicals, antimicrobial agents and silicone elastomers.
• Such ingredients may be mixed into the liquid composition before granulation or mixed with the solid particulate carrier composition before granulation or they can be mixed to the granulated dry composition.
• Antidandruff agents useful herein include compounds such as pyridinethione salts, selenium compounds such as selenium disulfide, and soluble antidandruff agents.
• Hair dyeing agents useful herein include oxidation hair dyeing agents, no-oxidation dyeing agents and semi-permanent dyeing agents.
• Oxidation dye agents penetrate into hair, and chemically impart a colour to the hair by means of colour formation resulting from oxidative polymerisation under the action of an oxidation agent.
• Non-oxidation dyeing agents are used for semi-permanent or non-permanent hair dyeing.
• Semi-permanent or non-oxidation dyeing agents are sometimes also referred to as direct dyes.
• Semi-permanent dyeing will usually colour human hair for up to six subsequent shampoo washes, although a high proportion of colour is often lost after 2 or 3 washes.
• Semi-permanent hair dyeing compositions are usually provided as single- component products, and may contain a variety of additives in addition to a direct dye.
• Conditioners useful herein are typically in the form of organic cationic conditioning agents for the purpose of providing more hair grooming.
• Such cationic conditioning agents may include quaternary nitrogen derivatives of cellulose ethers; homopolymers of dimethyldiallyl ammonium chloride; copolymers of acrylamide and dimethyldiallyl ammonium chloride;
• stearyltrimethylammonium chloride may also be employed in the compositions as a cationic conditioning agent.
• a cationic deposition aid may also be used.
• the cationic deposition aid may be a polymer or be formed from two or more types of monomers.
• the molecular weight of the polymer will generally be 5,000 and 10,000,000, typically at least 10,000 alternatively 100,000 to 2,000,000.
• the polymers will have cationic nitrogen containing groups such as quaternary ammonium or protonated amino groups, or a mixture thereof.
• the cationic charge density has been found to need to be at least 0.1 meq/g, alternatively above 0.8 or higher.
• the cationic charge density should not exceed 4 meq/g, alternatively it is less than 3, alternatively less than 2 meq/g.
• the charge density may be measured using the Kjeldahl method and should be within the above limits at the desired pH of use, which will in general be from 3 to 9 and alternatively from 4 to 8.
• the cationic nitrogen-containing group will generally be present as a substituent on a fraction of the total monomer units of the cationic deposition polymer.
• the deposition aid is not a polymer it may contain spacer noncationic monomer units.
• Suitable cationic deposition aids include, for example:
• copolymers of l-vinyl-2-pyrrolidine and l-vinyl-3-methylimidazolium salt e.g., Chloride salt
• CTFA Cosmetic, Toiletry, and Fragrance Association
• Polyquaternium-16 such as those commercially available from BASF
• LUVIQUAT FC 370 copolymers of l-vinyl-2-pyrrolidine and dimethylaminoethyl methacrylate (referred to in the industry by CTFA as Polyquaternium-11) such as those commercially from Gar Corporation (Wayne, NJ, USA) under the GAFQUAT tradename (e.g., GAFQUAT 755N); cationic diallyl quaternary ammonium-containing polymer including, for example, dimethyldiallyammonium chloride homopolymer and copolymers of acrylamide and dimethydiallyammonium chloride, referred to in the industry (CTFA) as Polyquaternium-6 and Polyquaternium-7, respectively; mineral acid salts of aminoalkyl esters of homo-and co-polymers of unsaturated carboxylic acids having from 3 to 5 carbon atoms, as described in US 4009256; and cationic polyacrylamides as described in WO 95/22311.
• CTFA cationic diallyl quaternary ammonium
• cationic deposition aids that may be used include polysaccharide polymers, such as cationic cellulose derivatives and cationic starch derivatives.
• Cationic polysaccharide polymer materials suitable for use in compositions of the invention include those of the formula: A-O(R-N + R 1 R 2 R 3 X " ) wherein: A is an anhydroglucose residual group, such as starch or cellulose anhydroglucose residual, R is an alkylene oxyalkylene, polyoxyalkylene, or hydroxyalkylene group, or combination thereof, Rl, R2 and R3 independently are alkyl, aryl, alkylaryl, arylalkyl, alkoxyalkyl, or alkoxyaryl groups, each group containing up to 18 carbon atoms, and the total number of carbon atoms for each cationic moiety (i.e., the sum of carbon atoms in Rl, R2 and R3) alternatively being 20 or less, and X is an
• hydroxyethyl cellulose reacted with trimethyl ammonium substituted epoxide referred to in the industry (CTFA) as Polyquaternium 10.
• CTFA trimethyl ammonium substituted epoxide
• Another type of cationic cellulose includes the polymeric quaternary ammonium salts of hydroxyethyl cellulose reacted with lauryl dimethyl ammonium-substituted epoxide, referred to in the industry (CTFA) as Polyquaternium 24.
• cationic deposition aids that can be used include cationic guar gum derivatives, such as guar hydroxypropyltrimonium chloride (Commercially available from Celanese Corp. in their Jaguar trademark series).
• Other materials include quaternary nitrogen- containing cellulose ethers (e.g., as described in US 3962418, incorporated herein by reference), and copolymers of etherified cellulose and starch (e.g., as described in US 3958581,
• the cationic deposition aid may be put in the liquid composition or added in solid form to the particulate carrier composition .
• the granulated dry composition may contain proteins, like those extracted from wheat, soy, rice, corn, keratin, elastin or silk. Most are in the hydrolyzed form and they may also be quaternised to provide better performance.
• the perfume may be a fragrant odoriferous substance or a mixture of fragrant odoriferous substances including natural substances obtained by extraction of flowers, herbs, leaves, roots, barks, wood, blossoms or plants; artificial substances including mixtures of different natural oils or oil constituents; and synthetically produced substances.
• perfume ingredients that are useful include hexyl cinnamic aldehyde; amyl cinnamic aldehyde; amyl salicylate; hexyl salicylate; terpineol; 3,7- dimethyl-cis- 2,6- octadien-1-ol; 2,6-dimethyl-2-octanol; 2,6-dimethyl-7-octen-2-ol; 3,7- dimethyl-3-octanol; 3,7-dimethyl-trans-2,6-octadien-l-ol; 3,7-dimethyl-6- octen-1-ol; 3,7- dimethyl- 1-octanol; 2- methyl-3-(para-tert-butylphenyl)- propionaldehyde; 4-(4-hydroxy-4- methylpentyl)-3- cyclohexene-1- carboxaldehyde; tricyclodecenyl
• anisaldehyde 2-methyl-2-(para-iso-propylphenyl)-propionaldehyde; ethyl-3- methyl- 3- phenyl glycidate; 4-(para-hydroxyphenyl)-butan-2-one; 1 -(2,6,6- trimethyl-2-cyclohexen-l- yl)-2-buten-l-one; para-methoxyacetophenone; para-methoxy-alpha-phenylpropene; methyl- 2-n-hexyl-3-oxo-cyclopentane carboxylate; and undecalactone gamma.
• perfume ingredients include orange oil; lemon oil; grapefruit oil; bergamot oil; clove oil; dodecalactone gamma; methyl-2-(2-pentyl-3-oxo-cyclopentyl) acetate; beta-naphthol methylether; methyl-beta-naphthylketone; coumarin; decylaldehyde; benzaldehyde; 4-tert-butylcyclohexyl acetate; alpha, alpha- dimethylphenethyl acetate;
• cedryl acetate para-tert-butylcyclohexyl acetate; patchouli; olibanum resinoid; labdanum; vetivert; copaiba balsam; fir balsam; and condensation products of: hydroxycitronellal and methyl anthranilate; hydroxycitronellal and indol; phenyl acetaldehyde and indol; 4- (4- hydroxy- 4- methyl pentyl)-3-cyclohexene-l -carboxaldehyde, and methyl anthranilate.
• perfume ingredients are geraniol; geranyl acetate; linalool; linalyl acetate; tetrahydrolinalool; citronellol; citronellyl acetate; dihydromyrcenol; dihydromyrcenyl acetate; tetrahydromyrcenol; terpinyl acetate; nopol; nopyl acetate; 2-phenylethanol; 2- phenylethyl acetate; benzyl alcohol; benzyl acetate; benzyl salicylate; benzyl benzoate;
• Pediculicides for control of lice infestations may be present in the granulated dry composition.
• Suitable pediculicides are well known in the art and include, for example, pyrethrins such as those described in US 4668666.
• a pH adjusting agent may be used to adjust pH of the granulated dry composition, within the range of 4 to 9 alternatively within the range of 5 to 7.
• Any water soluble acid such as a carboxylic acid or a mineral acid is suitable.
• Suitable acids include mineral acids such as hydrochloric acid, sulphuric acid, and phosphoric acid, monocarboxylic acid such as acetic acid and lactic acid, and polycarboxylic acids such as succinic acid, adipic acid, and citric acid.
• Typical pigments are iron oxides and titanium dioxide which may be present in either the dry granulated composition in the amount of 0.1 to 30 wt.%, alternatively 0.5 to 20 wt.% alternatively 0.8 to 10 wt.%.
• Sunscreen materials include those materials which absorb ultraviolet light from 290- 320 nanometers (the UV-B region) such as, para-aminobenzoic acid derivatives and cinnamates such as octyl methoxycinnamate and those which absorb ultraviolet light in the range of 320-400 nanometers (the UV-A region) such as benzophenones and butyl methoxy dibenzoylmethane.
• sunscreen materials which may be used herein are 2-ethoxyethyl p-methoxycinnamate; menthyl anthranilate; homomenthyl salicylate; glyceryl p-aminobenzoate; isobutyl p-aminobenzoate; isoamyl p-dimethylaminobenzoate; 2-hydroxy-4- methoxybenzophenones sulfonic acid; 2,2'-dihydroxy-4-methoxybenzophenone; 2-hydroxy-4- methoxybenzophenone; 4-mono and 4-bis(3-hydroxy-propyl)amino isomers of ethyl benzoate; and 2-ethylhexyl p-dimethylaminobenzoate
• Vitamins are a class of organic compounds that must be ingested part of the diet for humans (and other organisms) in order to maintain health and well being. Some vitamins also have beneficial effects when applied topically and for this reason are popular ingredients in various personal care formulations, where it is desired that the vitamin should be released after the formulation has been applied to the skin or hair.
• Vitamins comprise a variety of different organic compounds such as alcohols, acids, sterols, and quinones. They may be classified into two solubility groups: lipid-soluble vitamins and water-soluble vitamins. Lipid-soluble vitamins that have utility in personal care
• vitamin A retinol
• vitamin D 2 ergocalciferol
• vitamin D 3 cholecalciferol
• vitamin K 1 phytonadione
• tocopherol vitamin E
• Water-soluble vitamins that have utility in personal care formulations include ascorbic acid (vitamin C), thiamin (vitamin B 1 ) niacin (nicotinic acid), niacinamide (vitamin B 3 ), riboflavin (vitamin B 2 ), pantothenic acid (vitamin B 5 ), biotin, folic acid, pyridoxine (vitamin B 6 ), and cyanocobalamin (vitamin B 12 ).
• Vitamin derivatives may be more amenable to certain kinds of personal care formulations. For example a lipid-soluble vitamin may be derivatised to produce a water-soluble material that is easier to incorporate into a water-based formulation.
• Retinol and tocopherol are two lipid- soluble vitamins that are particularly useful in skin care compositions and consequently there are many different derivatives of these two vitamins that are used in personal care compositions.
• Derivatives of retinol include retinyl palmitate (vitamin A palmitate), retinyl acetate (vitamin A acetate), retinyl linoleate (vitamin A linoleate), and retinyl propionate (vitamin A propionate).
• tocopherol Derivatives of tocopherol include tocopheryl acetate (vitamin E acetate), tocopheryl linoleate (vitamin E linoleate), tocopheryl succinate (vitamin E succinate), tocophereth-5, tocophereth-10, tocophereth-12, tocophereth-18, tocophereth-50 (ethoxylated vitamin E derivatives), PPG-2 tocophereth-5, PPG-5 tocophereth-2, PPG-10 tocophereth-30, PPG-20 tocophereth-50, PPG-30 tocophereth-70, PPG-70 tocophereth-100 (propoxylated and ethoxylated vitamin E derivatives), and sodium tocopheryl phosphate.
• Derivatives of ascorbic acid such as ascorbyl palmitate, ascorbyl dipalmitate, ascorbyl glucoside, ascorbyl tetraisopalmitate, and tetrahexadecyl ascorbate may also be used, as may vitamin derivatives incorporating two different vitamins in the same compound, for example ascorbyl tocopheryl maleate, potassium ascorbyl tocopheryl phosphate or tocopheryl nicotinate.
• Provitamins may also be used, such as panthenol.
• the dry granulated composition may contain one or more water-soluble emollients such as lower molecular weight aliphatic diols such as propylene glycol and butylene glycol; polyols such as glycerine and sorbitol; and polyoxyethylene polymers such as polyethylene glycol 200.
• water-soluble emollients such as lower molecular weight aliphatic diols such as propylene glycol and butylene glycol
• polyols such as glycerine and sorbitol
• polyoxyethylene polymers such as polyethylene glycol 200.
• the specific type and amount of water soluble emollient(s) employed will vary depending on the desired aesthetic characteristics of the composition, and is readily determined by one skilled in the art.
• Organic butters such as mango, cocoa, shea butters, may be used in the dry granulated composition. Typically these butters are added to the liquid composition and may undergo a heating step to be molten either before addition to the liquid composition, or the liquid composition may be heated to allow for the melting of the butters.
• Polyorganosiloxane elastomers may also be used herein.
• the polyorganosiloxane elastomer may be in combination with a polyorganosiloxane oil be dispersed in low polarity organic solvents such as isododecane.
• the polyorganosiloxane elastomers may have an alkyl, polyether, amine or other organofunctional group grafted onto the polyorganosiloxane elastomer backbone.
• Suitable polyorganosiloxanes elastomers are taught in US 5811487, US 5880210, US 6200581, US 5236986, US 6331604, US 6262170, US 6531540 and US 6365670 .
• Typical additional ingredients which may be included for specific care of the keratinous substrates include but are not limited to soothing ingredients, for example aloe vera; refreshing ingredients, for example menthyl lactate; and fragrance.
• the liquid composition is contacted with the solid particulate carrier composition in a mixer in which droplets of the liquid
• the composition become agglomerated with carrier particles.
• Contact may for example be in a granulating mixer, an extruder, a compactor or in a high shear or low shear mixer.
• the liquid composition is contacted with the solid particulate carrier composition in a granulating mixer in which the agglomerated product is kept in particulate form.
• the granulating mixer is generally a high shear mixer such as an EirichTM pan granulator, a SchugiTM mixer, a Paxeson-KellyTM twin core blender, a Lodige ploughshare mixer, an AeromaticTM fluidized bed granulator or a PharmaTM drum mixer or a Glatt® fluid bed system.
• the liquid composition is sprayed onto the solid particulate carrier composition while the solid particulate carrier composition carrier is being agitated or fluidized.
• the liquid composition may alternatively be poured into the mixer instead of spraying.
• the dry granulated composition is generally collected from the mixer and packaged.
• the product from a vertical continuous granulating mixer may be fed to a fluidised bed which cools and/or dries the granules and fluidises them for transport to a packing station.
• the distribution of granules at the outlet of the granulating mixer may include fines and oversize material.
• the fines can for example be recovered in a filter coupled with the fluidized bed cooler and/or in a classification unit and recycled with fresh particles feeding the mixer.
• Oversize material may be collected, crushed down and mixed with the granulated product in a fluidized bed.
• the liquid composition and the solid particulate carrier composition are combined in an apparatus which does not maintain the mixture as separate granules, for example an extruder or a compactor, the mixture may be converted into granules by flaking, by comminuting an extruded strand or by spheronization after extrusion.
• One form of granulating mixer is a vertical continuous granulating mixer comprising blades rotating within a tubular housing and having an inlet for solid particulate carrier composition and a spray inlet for the liquid composition to contact the solid particulate carrier composition above the blades.
• the blades are mounted on a substantially vertical shaft aligned with the housing and rotating within the housing.
• the blades have a predetermined clearance from the inner wall of the housing.
• Contact with the liquid agglomerates the particles into granules; the liquid acts as a binder by absorbing the kinetic energy of colliding particles.
• the blades maintain the solid particles and granules in motion and prevent agglomeration into granules which are too large.
• the ratio of the weight of liquid composition to the weight of solid particulate carrier composition used to produce the granulated dry composition can be varied within wide limits. Generally this ratio is at least 1:99 and may be up to 80:20 or even higher provided that the granules produced are stable and do not agglomerate further under the forces to which they are subjected while being transported. Alternatively, the ratio of the weight of liquid composition fed to the mixer to the weight of solid particulate carrier composition fed to the mixer is in the range 5:95 to 80:20.
• the weight ratio of non-elastomeric polyorganosiloxane to solid particulate carrier in the dry granulated composition produced after drying is in the range 2:98 to 80:20, alternatively 4:96 to 40:60 alternatively 15:85 to 75:25.
• the mean particle diameter of the granules are typically 0.01 to 2 mm, alternatively 0.02 to 1.5 mm.
• the dry granulated composition comprises at least 80 wt%, alternatively 90 wt%, alternatively 95 wt% of the solid particulate carrier and the non-elastomeric polyorganosiloxane.
• the solid particulate carrier composition is typically treated in conditions minimizing the risk of volatilization of the components. This may be done by choosing ingredients of low volatility such as non volatile
• the granulated dry compositions can be used as a dry cleanser for keratinous substrates such as hair or skin.
• the granulated dry composition may be deposited on hair by sprinkling or spraying or with an applicator, such as a brush or a sponge. It may further be left to stand on hair and absorb sebum and deposit the additive substance (when needed). It is further removed from hair by brushing or air blowing. Hair may then be set as usual.
• the granulated dry cleanser composition may be deposited on the skin by sprinkling or spraying or with an applicator, such as a brush or a sponge. It may further be spread and rubbed onto skin to release the care agents. It may be further removed from the skin by air blowing, swiping or any other convenient way.
• the dry granulated composition may be suspended in a propellant and applied through an aerosol.
• propellant material is not critical and any nontoxic substance which develops the requisite pressure may be used to perform the essentially mechanical function of driving the volatile liquid and the dry granulated composition out of the aerosol container. All propellants which are commonly used in aerosol cans are suitable for use in this application. Many organic substances or mixtures thereof, may serve as propellant. Liquids with boiling points ranging from -30° to 82 0 C may be used as the volatile liquid in conjunction with the granulated dry composition.
• esters such as ethyl acetate and methyl acetate
• ketones such as methyl ethyl ketone and acetone
• hydrocarbons such as the straight chained alkanes, butanes, pentane and hexane
• cyclic hydrocarbons such as cyclopropane, cyclobutane, cyclopentane, and cyclohexane
• branched chain hydrocarbons such as 2,2- dimethyl propane, methyl pentanes, dimethyl pentanes and dimethyl butanes
• alcohols such as ethyl alcohol and iso-propyl alcohol
• ethers such as dimethyl ether, diethyl ether, diisopropyl ether, methyl ethers of ethyl, isopropyl, propyl, n-butyl, t-butyl and isobutyl alcohols, ethyl ethers of n
• Compressed gas may be used, such as nitrogen, carbone dioxide, air.
• the application of the granulated dry compositions generally provides conditioning benefits of the keratinous substrate, e.g. skin and hair.
• Benefits obtained from using the granulated dry compositions on hair according to the invention include typically sebum absorption, hair conditioning, volume, softness, detangling ease, shine/luster, color protection/retention, styling, strengthening, deposition of an additive substance.
• Benefits obtained from using the granulated dry compositions on skin include body fluids absorption, moisture management, deposition of an additive substance, skin softness, suppleness, moisturization, emolliency.
• the powder form provides convenience (ease of transport), new product format and a preservative is not mandatory.
• a liquid solution containing polyorganosiloxane and optionally other additives was poured very slowly into a high shear mixer in which the solid particulate carrier is placed. The mixture was stirred continuously until a particulate material is obtained. The particulate material was then passed over an Aeromatic fluid bed for 10 minutes at 5O 0 C.
• the dry compositions are described in the tables below. Evaluations carried out on powders
• Olive oil was used as "artificial" sebum.
• Olive oil contains a high amount of triglycerides and fatty acids, which are the main components of natural sebum.
• Granulated dry composition sensory feel panelists were asked to touch the powders with their fingers and rated them vs. a commercially available dry cleanser product (rated at a baseline of 0) or when specified, the solid particulate carrier. A softer sensory feel vs. the reference was reported as "+”. On the contrary, if the granulated dry composition was less soft, it was reported as "-”.
• Crosspolymer (Dow Corning® 9509 Silicone Elastomer Suspension) was granulated on native corn starch following the granulation process described above.
• Example 5 The Amodimethicone fluid of 3500 mm 2 /s used in the emulsion of Example 3 was mixed directly with olive oil and was found not miscible, demonstrating the absence of absorbency properties of the Amodimethicone fluid.
• Example 5 The Amodimethicone fluid of 3500 mm 2 /s used in the emulsion of Example 3 was mixed directly with olive oil and was found not miscible, demonstrating the absence of absorbency properties of the Amodimethicone fluid.
• Cetyl Dimethicone (Dow Corning® 2502 Cosmetic Fluid), having a viscosity of 45 mm 2 /s, was granulated on calcium silicate.
• Example 3 The aqueous microemulsion of Amodimethicone used in Example 3 was blended with Vegetol The Vert LC 412 hydro (Propylene Glycol (and) Water (and) Camellia Sinensis Leaf Extract by Gattefosse) and then granulated on calcium silicate.
• Vert LC 412 hydro Propylene Glycol (and) Water (and) Camellia Sinensis Leaf Extract by Gattefosse
• Example 3 The aqueous microemulsion of Amodimethicone used in Example 3 was blended with Silkerine HL (Sericin by Varna Pharma) and then granulated on calcium silicate.
• Example 14 The aqueous microemulsion of Amodimethicone used in Example 3 was blended with Vegetol Aloes GR 198 hydro (Propylene Glycol (and) Water (and) Aloe Ferox Leaf Extract by Gattefosse) and then granulated on calcium silicate.
• Vegetol Aloes GR 198 hydro Propylene Glycol (and) Water (and) Aloe Ferox Leaf Extract by Gattefosse
• Circulatoire 318 HS Propylene glycol, Cupressus sempervirens cone extract, Hamamelis virginiana leaf extract, Ruscus aculeatus root extract, Vitis vinifera leaf extract by Alban Muller
• HS Circulatoire 318 HS (Propylene glycol, Cupressus sempervirens cone extract, Hamamelis virginiana leaf extract, Ruscus aculeatus root extract, Vitis vinifera leaf extract by Alban Muller) and then granulated on calcium silicate.
• Example 3 The aqueous microemulsion of Amodimethicone used in Example 3 was blended with Phenyltrimethicone, having a viscosity of 22.5 mm 2 /s, known as shine agent, and granulated on calcium silicate.
• Phenyltrimeticone (Dow Corning® 556 Cosmetic Grade Fluid) was granulated on calcium silicate. Table 7 (dry compositions)
• Mango butter (Dow Corning® 7-3123 Mango Blend Emulsion) was granulated on calcium silicate.
• Example 27 The aqueous microemulsion of Amodimethicone as used in Example 3 was granulated on rice starch.
• Example 27 The aqueous microemulsion of Amodimethicone as used in Example 3 was granulated on rice starch.
• Example 3 The aqueous microemulsion of Amodimethicone as used in Example 3 was granulated on native corn starch.
• Wood flour was used as received.
• Example 3 The aqueous microemulsion of Amodimethicone as used in Example 3 was granulated on wood flour.
• Example 3 The aqueous microemulsion of Amodimethicone as used in Example 3 was granulated on zeolite.
• Example 3 The aqueous microemulsion of Amodimethicone as used in Example 3 was granulated on a mix of calcium silicate and iron oxide pigment (Unipure brown LC881 by LCW Sensient).

Landscapes

• Health & Medical Sciences (AREA)
• Life Sciences & Earth Sciences (AREA)
• Animal Behavior & Ethology (AREA)
• General Health & Medical Sciences (AREA)
• Public Health (AREA)
• Veterinary Medicine (AREA)
• Birds (AREA)
• Epidemiology (AREA)
• Chemical & Material Sciences (AREA)
• Inorganic Chemistry (AREA)
• Cosmetics (AREA)

Priority Applications (5)

Applications Claiming Priority (2)

Related Child Applications (2)

Publications (2)

Family

ID=43586746

Family Applications (1)

Country Status (6)

Cited By (14)

Families Citing this family (10)

Citations (39)

Family Cites Families (19)

• 2010
  • 2010-08-03 WO PCT/US2010/044182 patent/WO2011019539A2/en not_active Ceased
  • 2010-08-03 CN CN2010800356923A patent/CN102686280A/zh active Pending
  • 2010-08-03 EP EP10739823A patent/EP2464428A2/en not_active Withdrawn
  • 2010-08-03 US US13/390,130 patent/US9724289B2/en not_active Expired - Fee Related
  • 2010-08-03 KR KR1020127006358A patent/KR20120050478A/ko not_active Withdrawn
  • 2010-08-03 JP JP2012524740A patent/JP2013501788A/ja active Pending
• 2015
  • 2015-08-28 JP JP2015168624A patent/JP6196266B2/ja not_active Expired - Fee Related
• 2017
  • 2017-06-30 US US15/639,630 patent/US20170296455A1/en not_active Abandoned

Patent Citations (42)

Non-Patent Citations (1)

Also Published As

Similar Documents

Legal Events